Literature DB >> 29906414

Guide RNA selection for CRISPR-Cas9 transfections in Plasmodium falciparum.

Jose M Ribeiro1, Meera Garriga1, Nicole Potchen1, Anna K Crater1, Ankit Gupta1, Daisuke Ito1, Sanjay A Desai2.   

Abstract

CRISPR-Cas9 mediated genome editing is addressing key limitations in the transfection of malaria parasites. While this method has already simplified the needed molecular cloning and reduced the time required to generate mutants in the human pathogen Plasmodium falciparum, optimal selection of required guide RNAs and guidelines for successful transfections have not been well characterised, leading workers to use time-consuming trial and error approaches. We used a genome-wide computational approach to create a comprehensive and publicly accessible database of possible guide RNA sequences in the P. falciparum genome. For each guide, we report on-target efficiency and specificity scores as well as information about the genomic site relevant to optimal design of CRISPR-Cas9 transfections to modify, disrupt, or conditionally knockdown any gene. As many antimalarial drug and vaccine targets are encoded by multigene families, we also developed a new paralog specificity score that should facilitate modification of either a single family member of interest or multiple paralogs that serve overlapping roles. Finally, we tabulated features of successful transfections in our laboratory, providing broadly useful guidelines for parasite transfections. Molecular studies aimed at understanding parasite biology or characterising drug and vaccine targets in P. falciparum should be facilitated by this comprehensive database. Published by Elsevier Ltd.

Entities:  

Keywords:  CRISPR-Cas9 design; DNA transfection; Guide RNA; Malaria; Multigene families; Plasmodium falciparum

Mesh:

Substances:

Year:  2018        PMID: 29906414      PMCID: PMC9093057          DOI: 10.1016/j.ijpara.2018.03.009

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   4.330


  43 in total

Review 1.  Ion and nutrient uptake by malaria parasite-infected erythrocytes.

Authors:  Sanjay A Desai
Journal:  Cell Microbiol       Date:  2012-04-19       Impact factor: 3.715

Review 2.  Critical Steps in Protein Export of Plasmodium falciparum Blood Stages.

Authors:  Tobias Spielmann; Tim-Wolf Gilberger
Journal:  Trends Parasitol       Date:  2015-10

Review 3.  Microhomology-Mediated End Joining: A Back-up Survival Mechanism or Dedicated Pathway?

Authors:  Agnel Sfeir; Lorraine S Symington
Journal:  Trends Biochem Sci       Date:  2015-10-01       Impact factor: 13.807

4.  Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression.

Authors:  Lei S Qi; Matthew H Larson; Luke A Gilbert; Jennifer A Doudna; Jonathan S Weissman; Adam P Arkin; Wendell A Lim
Journal:  Cell       Date:  2013-02-28       Impact factor: 41.582

5.  Microhomology-mediated deletion and gene conversion in African trypanosomes.

Authors:  Lucy Glover; Junho Jun; David Horn
Journal:  Nucleic Acids Res       Date:  2010-10-21       Impact factor: 16.971

6.  CRISPR-Cas9-Mediated Genome Editing in Leishmania donovani.

Authors:  Wen-Wei Zhang; Greg Matlashewski
Journal:  MBio       Date:  2015-07-21       Impact factor: 7.867

Review 7.  Strategies for precision modulation of gene expression by epigenome editing: an overview.

Authors:  Benjamin I Laufer; Shiva M Singh
Journal:  Epigenetics Chromatin       Date:  2015-09-17       Impact factor: 4.954

8.  Improving CRISPR-Cas nuclease specificity using truncated guide RNAs.

Authors:  Yanfang Fu; Jeffry D Sander; Deepak Reyon; Vincent M Cascio; J Keith Joung
Journal:  Nat Biotechnol       Date:  2014-01-26       Impact factor: 54.908

9.  Malaria parasites utilize both homologous recombination and alternative end joining pathways to maintain genome integrity.

Authors:  Laura A Kirkman; Elizabeth A Lawrence; Kirk W Deitsch
Journal:  Nucleic Acids Res       Date:  2013-10-01       Impact factor: 16.971

10.  Efficient CRISPR-Cas9-mediated genome editing in Plasmodium falciparum.

Authors:  Jeffrey C Wagner; Randall J Platt; Stephen J Goldfless; Feng Zhang; Jacquin C Niles
Journal:  Nat Methods       Date:  2014-08-10       Impact factor: 28.547

View more
  7 in total

1.  Ribozyme-mediated, multiplex CRISPR gene editing and CRISPR interference (CRISPRi) in rodent-infectious Plasmodium yoelii.

Authors:  Michael P Walker; Scott E Lindner
Journal:  J Biol Chem       Date:  2019-05-01       Impact factor: 5.157

Review 2.  CRISPR/Cas9 Editing of the Plasmodium falciparum Genome.

Authors:  Sophie Adjalley; Marcus Chee San Lee
Journal:  Methods Mol Biol       Date:  2022

Review 3.  Cutting back malaria: CRISPR/Cas9 genome editing of Plasmodium.

Authors:  Marcus C S Lee; Scott E Lindner; Jose-Juan Lopez-Rubio; Manuel Llinás
Journal:  Brief Funct Genomics       Date:  2019-09-24       Impact factor: 4.241

4.  Live-Cell FRET Reveals that Malaria Nutrient Channel Proteins CLAG3 and RhopH2 Remain Associated throughout Their Tortuous Trafficking.

Authors:  Moaz Ahmad; Javier Manzella-Lapeira; Gagandeep Saggu; Daisuke Ito; Joseph A Brzostowski; Sanjay A Desai
Journal:  mBio       Date:  2020-09-08       Impact factor: 7.867

5.  A Leak-Free Inducible CRISPRi/a System for Gene Functional Studies in Plasmodium falciparum.

Authors:  Xiaoying Liang; Rachasak Boonhok; Faiza Amber Siddiqui; Bo Xiao; Xiaolian Li; Junling Qin; Hui Min; Lubin Jiang; Liwang Cui; Jun Miao
Journal:  Microbiol Spectr       Date:  2022-05-05

6.  Kinetic Tracking of Plasmodium falciparum Antigens on Infected Erythrocytes with a Novel Reporter of Protein Insertion and Surface Exposure.

Authors:  Jinfeng Shao; Gunjan Arora; Javier Manzella-Lapeira; Joseph A Brzostowski; Sanjay A Desai
Journal:  mBio       Date:  2022-04-14       Impact factor: 7.786

Review 7.  Diverse target gene modifications in Plasmodium falciparum using Bxb1 integrase and an intronic attB.

Authors:  Praveen Balabaskaran-Nina; Sanjay A Desai
Journal:  Parasit Vectors       Date:  2018-10-17       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.